| Identification | Back Directory | [Name]
17-Hydroxy-androstano[2,3-d]isoxazole | [CAS]
80651-65-6 | [Synonyms]
Cefotetan Impurity 17
17-Hydroxy-androstano[2,3-d]isoxazole
17β-Hydroxy-androstano[2,3-d]isoxazole
(5α,17β)-androst-2-eno[2,3-d]isoxazol-17-ol
Androst-2-eno[2,3-d]isoxazol-17-ol, (5α,17β)- | [Molecular Formula]
C20H29NO2 | [MOL File]
80651-65-6.mol | [Molecular Weight]
315.45 |
| Chemical Properties | Back Directory | [Melting point ]
179.8-182.0 °C | [Boiling point ]
456.9±45.0 °C(Predicted) | [density ]
1.139±0.06 g/cm3(Predicted) | [solubility ]
DMF: 25 mg/ml; DMF:PBS (pH 7.2) (1:4): 0.1 mg/ml; DMSO: 20 mg/ml; Ethanol: 15 mg/ml | [form ]
A crystalline solid | [pka]
15.08±0.60(Predicted) |
| Hazard Information | Back Directory | [Description]
17β-Hydroxy-androstano[2,3-d]isoxazole (Item No. 17928) is an analytical reference standard categorized as an anabolic androgenic steroid. 17β-Hydroxy-androstano[2,3-d]isoxazole is regulated as a Schedule III compound in the United States. This product is intended for research and forensic applications. | [References]
[1] CHRISTOPHER C. WALLER . In vivo and in vitro metabolism of the designer anabolic steroid furazadrol in thoroughbred racehorses[J]. Journal of pharmaceutical and biomedical analysis, 2016, 124: Pages 198-206. DOI: 10.1016/j.jpba.2016.02.031 |
|
|